Sign in
4

Changes in Ownership

InMed Pharmaceuticals Inc. Filed Acc 0001213900-22-009673

Options or other derivatives

  • See Remarks acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
WOUDENBERG MICHAEL See Remarks 2022-02-23 Grant or award · Employee Stock Option (Right to Buy) +5,000 96,060 D
Loading xslF345X03/ownership.xml…